These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16408974)

  • 21. [Biochemical mechanisms of the DNA cleavage induced by NCS-chromophore].
    Ohtsuki K
    Seikagaku; 1996 Dec; 68(12):1817-24. PubMed ID: 9014491
    [No Abstract]   [Full Text] [Related]  

  • 22. Modeling study of the structure of the macromolecular antitumor antibiotic neocarzinostatin. Origin of the stabilization of the chromophore.
    Ishiguro M; Imajo S; Hirama M
    J Med Chem; 1991 Aug; 34(8):2366-73. PubMed ID: 1831507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress toward the total synthesis of (+)-aldosterone: synthesis of the A-D rings.
    Bear BR; Parnes JS; Shea KJ
    Org Lett; 2003 May; 5(10):1613-6. PubMed ID: 12735734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel synthesis of beta-lactam fused cyclic enediynes by intramolecular Kinugasa reaction.
    Pal R; Basak A
    Chem Commun (Camb); 2006 Jul; (28):2992-4. PubMed ID: 16832514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A stereoselective approach to the azaspiro[5.5]undecane ring system using a conjugate addition/dipolar cycloaddition cascade: application to the total synthesis of (+/-)-2,7,8-epi-perhydrohistrionicotoxin.
    Wilson MS; Padwa A
    J Org Chem; 2008 Dec; 73(24):9601-9. PubMed ID: 18715039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biologically active site of neocarzinostatin-chromophore.
    Koide Y; Ito A; Edo K; Ishida N
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4425-8. PubMed ID: 2951017
    [No Abstract]   [Full Text] [Related]  

  • 27. Solution NMR structure investigation for releasing mechanism of neocarzinostatin chromophore from the holoprotein.
    Takashima H; Yoshida T; Ishino T; Hasuda K; Ohkubo T; Kobayashi Y
    J Biol Chem; 2005 Mar; 280(12):11340-6. PubMed ID: 15640161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neocarzinostatin chromophore: purification of the major active form and characterization of its spectral and biological properties.
    Napier MA; Holmquist B; Strydom DJ; Goldberg IH
    Biochemistry; 1981 Sep; 20(19):5602-8. PubMed ID: 6457635
    [No Abstract]   [Full Text] [Related]  

  • 29. Binding and cleavage characteristics of the complexes formed between the neocarzinostatin chromophore and single site containing oligonucleotides.
    Stassinopoulos A; Goldberg IH
    Bioorg Med Chem; 1995 Jun; 3(6):713-21. PubMed ID: 7582949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absolute configuration of the amino sugar moiety of the neocarzinostatin chromophore.
    Edo K; Akiyama Y; Saito K; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1986 Nov; 39(11):1615-9. PubMed ID: 2947887
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of activation of the antitumor antibiotic neocarzinostatin by mercaptan and sodium borohydride.
    Hensens OD; Goldberg IH
    J Antibiot (Tokyo); 1989 May; 42(5):761-8. PubMed ID: 2524463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neocarzinostatin chromophore: presence of a highly strained ether ring and its reaction with mercaptan and sodium borohydride.
    Hensens OD; Dewey RS; Liesch JM; Napier MA; Reamer RA; Smith JL; Albers-Schönberg G; Goldberg IH
    Biochem Biophys Res Commun; 1983 Jun; 113(2):538-47. PubMed ID: 6223633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective total synthesis of (+)-Scyphostatin via a pi-facially selective Diels-Alder reaction.
    Takagi R; Miyanaga W; Tojo K; Tsuyumine S; Ohkata K
    J Org Chem; 2007 May; 72(11):4117-25. PubMed ID: 17477576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epoxide-initiated electrophilic cyclization of azides: a novel route for the stereoselective construction of azabicyclic ring systems and total synthesis of (+/-)-indolizidine 167B and 209D.
    Reddy PG; Varghese B; Baskaran S
    Org Lett; 2003 Feb; 5(4):583-5. PubMed ID: 12583775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sources of hydrogen abstraction by activated neocarzinostatin chromophore.
    Chin DH; Goldberg IH
    Biochemistry; 1993 Apr; 32(14):3611-6. PubMed ID: 8466903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photoactivation of neocarzinostatin chromophore: photo-induced cycloaromatization via naphthoate participation.
    Gomibuchi T; Hirama M
    J Antibiot (Tokyo); 1995 Jul; 48(7):738-40. PubMed ID: 7649879
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies toward the synthesis of oximidines I and II.
    Haack T; Kurtkaya S; Snyder JP; Georg GI
    Org Lett; 2003 Dec; 5(26):5019-22. PubMed ID: 14682754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective synthesis of the C1-C13 fragment of 2,3-dihydrodorrigocin A.
    Le Brazidec JY; Gilson CA; Boehm MF
    J Org Chem; 2005 Sep; 70(20):8212-5. PubMed ID: 16277352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unstability of neocarzinostatin-chromophore.
    Edo K; Sato H; Saito K; Akiyama Y; Kato M; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1986 Apr; 39(4):535-40. PubMed ID: 2423490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of a NO-releasing prodrug of rofecoxib.
    Engelhardt FC; Shi YJ; Cowden CJ; Conlon DA; Pipik B; Zhou G; McNamara JM; Dolling UH
    J Org Chem; 2006 Jan; 71(2):480-91. PubMed ID: 16408954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.